Skip to main navigation
Skip to search
Skip to main content
New Jersey Institute of Technology Home
Help & FAQ
Home
Profiles
Research units
Facilities
Federal Grants
Research output
Press/Media
Search by expertise, name or affiliation
PIM kinases as therapeutic targets against advanced melanoma
Batool Shannan
, Andrea Watters
, Quan Chen
, Stefan Mollin
, Markus Dörr
, Eric Meggers
, Xiaowei Xu
, Phyllis A. Gimotty
, Michela Perego
, Ling Li
, Joseph Benci
, Clemens Krepler
, Patricia Brafford
, Jie Zhang
,
Zhi Wei
, Gao Zhang
, Qin Liu
, Xiangfan Yin
, Katherine L. Nathanson
, Meenhard Herlyn
Adina Vultur
Show 1 others
Show less
Research output
:
Contribution to journal
›
Article
›
peer-review
19
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'PIM kinases as therapeutic targets against advanced melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Advanced Melanoma
100%
PIM Kinase
100%
Therapeutic Target
100%
Melanoma
75%
Melanoma Cells
75%
Cell Proliferation
50%
Melanoma Patients
50%
Pim Kinase Inhibitor
50%
Three-dimensional (3D)
25%
Tumor
25%
Cell Viability
25%
Therapeutic Strategies
25%
Metastatic Melanoma
25%
Novel Therapeutic Targets
25%
Knockdown
25%
BRAF Inhibitor (BRAFi)
25%
Targeted Therapy
25%
SGI-1776
25%
Melanoma Model
25%
Cell Invasion
25%
PLX4720
25%
PIM-1
25%
PI3K Inhibitor
25%
Cell Tumor
25%
Tumor Growth in Vivo
25%
PIM3
25%
Tumor Tissue
25%
PIM2
25%
Tumor Resistance
25%
Promising Target
25%
Medicine and Dentistry
Nodular Melanoma
100%
Kinase
100%
Melanoma Cell
42%
Cell Proliferation
28%
Targeted Therapy
14%
Neoplasm
14%
Tumor Progression
14%
Cancer Treatment
14%
Cell Viability
14%
Cell Invasion
14%
Metastatic Melanoma
14%
N [3 (5 Chloro 1h pyrrolo[2,3 B]pyridine 3 Carbonyl) 2,4 Difluorophenyl]propanesulfonamide
14%
Tumor Resistance
14%
PIM2
14%
Cyclic AMP Dependent Protein Kinase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Neoplasm
20%
Tumor Growth
10%
Cyclic AMP Dependent Protein Kinase
10%
Tumor Resistance
10%
N [3 (5 Chloro 1h pyrrolo[2,3 B]pyridine 3 Carbonyl) 2,4 Difluorophenyl]propanesulfonamide
10%
Metastatic Melanoma
10%